Substance Use Disorders on the Rise for Survivors of Specific Cancers
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 12, 2024 -- The prevalence of substance use disorder (SUD) seems to be elevated among survivors of certain types of cancer, according to a study published online Jan. 11 in JAMA Oncology.
Katie F. Jones, Ph.D., from VA Boston Healthcare System, and colleagues describe cancer type-specific prevalence of SUD among adult cancer survivors in a cross-sectional study using data from the annually administered National Survey on Drug Use and Health for 2015 through 2020. The analyses included 6,101 adult cancer survivors.
The researchers found that the prevalence of active SUD was 3.83 percent among lifetime cancer survivors. The prevalence of SUD was highest in survivors of head and neck cancer (including mouth, tongue, lip, throat, and pharyngeal cancers), esophageal and gastric cancer, cervical cancer, and melanoma (9.36, 9.42, 6.24, and 6.20 percent, respectively). The most common SUD was alcohol use disorder overall (2.78 percent) and in survivors of head and neck cancer, cervical cancer, and melanoma. Cannabis use disorder was the most prevalent SUD in survivors of esophageal and gastric cancers (9.42 percent). The overall prevalence of active SUD was similar among respondents diagnosed with cancer in the past 12 months to that in the lifetime cancer survivor cohort (3.81 percent). Active SUD was higher in head and neck and cervical cancer survivors (18.73 and 15.70 percent, respectively).
"Findings of this study highlight subpopulations of adult cancer survivors who may benefit from efforts to integrate cancer and addiction care," the authors write.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Vaginal Cancer Incidence Increasing Globally
WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...
Nudging Both Clinicians, Patients May Increase Serious Illness Conversations
TUESDAY, July 2, 2024 -- Combining clinician- and patient-directed nudges may help to promote serious illness conversations (SICs) in cancer care, according to a study published...
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.